BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scott BM, Chen SK, Bhattacharyya N, Moalim AY, Plotnikov SV, Heon E, Peisajovich SG, Chang BSW. Coupling of Human Rhodopsin to a Yeast Signaling Pathway Enables Characterization of Mutations Associated with Retinal Disease. Genetics 2019;211:597-615. [PMID: 30514708 DOI: 10.1534/genetics.118.301733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, van Westen GJP, Heitman LH, IJzerman AP. G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example. Biochem Pharmacol 2021;187:114370. [PMID: 33338473 DOI: 10.1016/j.bcp.2020.114370] [Reference Citation Analysis]
2 Lengger B, Jensen MK. Engineering G protein-coupled receptor signalling in yeast for biotechnological and medical purposes. FEMS Yeast Res 2020;20:foz087. [PMID: 31825496 DOI: 10.1093/femsyr/foz087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Guan Y, Wang Y, Zheng D, Xie B, Xu P, Gao G, Zhong X. Generation of an RCVRN-eGFP Reporter hiPSC Line by CRISPR/Cas9 to Monitor Photoreceptor Cell Development and Facilitate the Cell Enrichment for Transplantation. Front Cell Dev Biol 2022;10:870441. [DOI: 10.3389/fcell.2022.870441] [Reference Citation Analysis]
4 Scott BM, Wybenga-Groot LE, McGlade CJ, Heon E, Peisajovich SG, Chang BSW. Screening of Chemical Libraries Using a Yeast Model of Retinal Disease. SLAS Discov 2019;24:969-77. [PMID: 31556794 DOI: 10.1177/2472555219875934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Garcia-Marcos M, Parag-Sharma K, Marivin A, Maziarz M, Luebbers A, Nguyen LT. Optogenetic activation of heterotrimeric G-proteins by LOV2GIVe, a rationally engineered modular protein. Elife 2020;9:e60155. [PMID: 32936073 DOI: 10.7554/eLife.60155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schardt JS, Jhajj HS, O'Meara RL, Lwo TS, Smith MD, Tessier PM. Agonist antibody discovery: Experimental, computational, and rational engineering approaches. Drug Discov Today 2022;27:31-48. [PMID: 34571277 DOI: 10.1016/j.drudis.2021.09.008] [Reference Citation Analysis]
7 Shaw WM, Yamauchi H, Mead J, Gowers GF, Bell DJ, Öling D, Larsson N, Wigglesworth M, Ladds G, Ellis T. Engineering a Model Cell for Rational Tuning of GPCR Signaling. Cell 2019;177:782-796.e27. [PMID: 30955892 DOI: 10.1016/j.cell.2019.02.023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 18.3] [Reference Citation Analysis]
8 Scott BM, Gutiérrez-Vázquez C, Sanmarco LM, da Silva Pereira JA, Li Z, Plasencia A, Hewson P, Cox LM, O'Brien M, Chen SK, Moraes-Vieira PM, Chang BSW, Peisajovich SG, Quintana FJ. Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease. Nat Med 2021;27:1212-22. [PMID: 34183837 DOI: 10.1038/s41591-021-01390-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
9 Lengger B, Hoch-Schneider EE, Jensen CN, Jakočiu Nas T, Petersen AA, Frimurer TM, Jensen ED, Jensen MK. Serotonin G Protein-Coupled Receptor-Based Biosensing Modalities in Yeast. ACS Sens 2022. [PMID: 35452231 DOI: 10.1021/acssensors.1c02061] [Reference Citation Analysis]